CDC will, through this FOA, fund four (4) awards to build and improve upon a number of HIV community care and service activities supported by US CDC, including community-based care for adult and OVC activities managed by implementing partners under six separate agreements that are ending in March 2016.
This FOA is a 5 year project aimed at strengthening Adult and Pediatric care and ART service delivery under India’s National AIDS Control Program (NACP) through technical assistance for clinical mentoring, quality improvement and capacity building with a focus on geographic area as per the President's Emergency Plan For AIDS Relief (PEPFAR) India’s Country Operational Plan.
The purpose of this Funding Opportunity Announcement (FOA) is to stimulate research in the pathogenesis of perinatal HIV-1 infection by elucidating HIV-1 immune responses in the setting of the infant’s evolving immune system and mechanisms of establishment and maintenance of HIV-1 latent viral reservoirs. The goal of this FOA is to gain knowledge to be used in the future development of strategies to induce HIV-1 remission.
The purpose of this FOA is to promote research to investigate the underlying molecular mechanisms of HIV infection-induced immune activation and inflammation in the presence of antiretroviral therapy (ART) agents and drugs of abuse. The ultimate goal is to obtain information for developing therapeutic interventions for attenuating chronic inflammation-associated comorbidities as well as for restoring or improving ART efficacy in HIV-infected drug-abusing populations.
The purpose of these cooperative agreements is to further Indian Health Service (IHS) health program objectives in the American Indian/Alaska Native (AI/AN) community with awareness, visibility, advocacy, and education efforts for the Behavioral Health (BH) and HIV/AIDS programs on a national scale and in the interest of improving Indian health care. This announcement includes two separate awards, each of which will be awarded as noted below. The purpose of the BH award is to promote behavioral health as central to the health and well-being of AI/AN communities.
The American Foundation for AIDS Research (AmFAR) announces the availability of support to community-based and other agencies for the development of prevention / education programs for those at risk due to IV drug use directly or through sexual contact with IV drug users. Areas which may be addressed are safer sex for IV drug users, safer needle use, and/or women of childbearing age whose partners are IV drug users.
The Centers for Disease Control and Prevention announces the availability of fiscal year 2016 funds for a cooperative agreement program for community-based organizations (CBOs) to develop and implement High-Impact Human Immunodeficiency Virus (HIV) Prevention Programs in the following two categories: Category A: HIV prevention services for high risk Young Men of Color Who Have Sex with Men and their partners regardless of age, gender, and race/ethnicity.
The purpose of this Funding Opportunity Announcement (FOA) is to invite basic research project grant applications for HIV Microbiome Centers to perform investigations on the role of HIV-induced dysbiosis and how this imbalance may induce and/or contribute to the occurrence of heart, lung, or blood (HLB) co-morbidities in HIV positive individuals. This FOA will support mechanistic studies that will use in vitro, in vivo, ex vivo, and in silico models applied to HIV research.
For this 2016 funding round, as in previous years, the Elton John AIDS Foundation (EJAF) invites letters of intent (LOIs) from any proposed project that is working with people who are most affected by HIV in the Americas, defined as the United States, Canada, Mexico, the Caribbean, or Central or South America.